Search for: "The Medicines Company v. Mylan Inc. et al"
Results 1 - 20
of 30
Sort by Relevance
|
Sort by Date
17 Mar 2020, 1:32 pm
Understanding FDA Recalls of Drugs and Medical Devices An FDA recall of a drug or medical device is the often voluntary action of a company to correct and/or remove a medicine or product from public circulation because it’s in violation of the laws and regulations that the FDA is charged with enforcing. [read post]
1 Nov 2017, 7:15 am
Mylan Inc., et al, 1-11-cv-01285 (ILND October 30, 2017, Order) (St. [read post]
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.;… [read post]
7 Sep 2011, 4:22 am
Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog)… [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
9 Mar 2011, 3:00 am
(Spicy IP) Malta: ‘They shall not pass’ – Maltese court hands down decision in a cross-border seizure case (regarding trade marked pharmaceuticals) against defendant (IPKat) Peru: PIIPA helps get to the root of maca biopiracy (IP tango) US: IP position critical to biotech investment (PatentlyBIOtech) US: Schering files for PTA calculation correction in respect of patent covering ‘Thrombin receptor antagonists’ (Patent Docs) US: Cellectis files patent infringement… [read post]
27 Feb 2011, 8:59 pm
Medicines Company v. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey:… [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
28 Sep 2010, 3:14 pm
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
31 Aug 2010, 10:01 pm
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
27 Apr 2010, 10:58 pm
Orthofix International N.V. et al. [read post]
22 Apr 2010, 3:51 am
Labs. et al (Orange Book Blog) (FDA Law Blog) Seroquel (Quetiapine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Astrazeneca et al v Anchen Pharmaceuticals et al (Patent Docs) Simcor (Niacin, Simvastatin) – US: District Court Delaware: Patent infringement complaint following Para IV challenge: Abbott Laboratories et al. v. [read post]
24 Mar 2010, 4:45 am
INPI (EPLAW) Lyrica (Pregabalin) – US: Patent infringement complaint filed following a Para IV certification: Pfizer Inc. et al. v. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
17 Feb 2010, 8:00 am
(patent infringement) 1/15: Pfizer Inc., Pharmacia Corp., Pharmacia & Upjohn Co., Pharmacia & Upjohn LLC, Pharmacia & Upjohn Company LLC, et al. v. [read post]
10 Feb 2010, 4:47 pm
Teva Parenteral Medicines Inc. et al. [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
18 Dec 2009, 9:59 am
12/2: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Novartis Corporation, et al. v. [read post]
